EP3238735 - CHLOROTOXIN POLYPEPTIDES AND CONJUGATES AND USES THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 17.06.2020 Database last updated on 24.08.2024 | |
Former | Request for examination was made Status updated on 11.05.2018 | ||
Former | The application has been published Status updated on 29.09.2017 | Most recent event Tooltip | 27.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Eisai Inc. 200 Metro Blvd. Nutley, NJ 07110 / US | [2023/52] |
Former [2019/23] | For all designated states Eisai Inc. 100 Tice Boulevard Woodcliff Lake, NJ 07677 / US | ||
Former [2017/44] | For all designated states Morphotek, Inc. 210 Welsh Pool Road Exton, PA 19341 / US | Inventor(s) | 01 /
SENTISSI, Abdellah 1 Highrock Road Dover, MA 02030 / US | 02 /
JACOBY, Douglas B. 34 Clovelly Road Wellesley, MA 02481 / US | [2017/44] | Representative(s) | Atkins, James Gordon John, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2017/44] | Application number, filing date | 17173578.0 | 04.02.2011 | [2017/44] | Priority number, date | US20100301615P | 04.02.2010 Original published format: US 301615 P | [2017/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3238735 | Date: | 01.11.2017 | Language: | EN | [2017/44] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.07.2017 | Classification | IPC: | A61K38/16, C07K14/435 | [2017/44] | CPC: |
C07K14/43522 (EP,CN,US);
C07K14/195 (KR);
A61K31/337 (EP,US);
A61K31/7068 (EP,US);
A61K38/16 (KR);
A61K47/60 (EP,US);
A61K47/6415 (EP,US);
A61K51/088 (US);
A61P13/08 (EP);
A61P15/00 (EP);
A61P17/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P37/04 (EP);
A61P9/00 (EP);
G01N33/57415 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/24] |
Former [2017/44] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | CHLOROTOXINPOLYPEPTIDE SOWIE KONJUGATE UND VERWENDUNGEN DAVON | [2017/44] | English: | CHLOROTOXIN POLYPEPTIDES AND CONJUGATES AND USES THEREOF | [2017/44] | French: | POLYPEPTIDES CHLOROTOXINES ET LEURS CONJUGUÉS ET UTILISATIONS | [2017/44] | Examination procedure | 30.05.2017 | Date on which the examining division has become responsible | 01.05.2018 | Amendment by applicant (claims and/or description) | 01.05.2018 | Examination requested [2018/24] | 22.06.2020 | Despatch of a communication from the examining division (Time limit: M06) | 04.01.2021 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP11740464.0 / EP2531206 | Fees paid | Renewal fee | 30.05.2017 | Renewal fee patent year 03 | 30.05.2017 | Renewal fee patent year 04 | 30.05.2017 | Renewal fee patent year 05 | 30.05.2017 | Renewal fee patent year 06 | 30.05.2017 | Renewal fee patent year 07 | 27.02.2018 | Renewal fee patent year 08 | 27.02.2019 | Renewal fee patent year 09 | 27.02.2020 | Renewal fee patent year 10 | 25.02.2021 | Renewal fee patent year 11 | 25.02.2022 | Renewal fee patent year 12 | 27.02.2023 | Renewal fee patent year 13 | 27.02.2024 | Renewal fee patent year 14 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO03101474 (TRANSMOLECULAR INC [US], et al) [A] 1-15 * page 5, line 24 - page 6, line 6 * * page 10, paragraph 2 * * page 12, line 13 - line 21 * * page 13, line 26 - line 28; figure 10; example 11; claims 1-15; sequence 27 *; | [A]WO2008088422 (AMGEN INC [US], et al) [A] 1-15 * abstract *; | [A]US2009004105 (CHENG ZHEN [US], et al) [A] 1-15 * paragraph [0024] * * paragraph [0106] * * paragraph [0132] *; | [E]WO2011142858 (HUTCHINSON FRED CANCER RES [US], et al) [E] 1-15 * claims 1-30; sequences 1-5 *; | [A] - TYTGAT J ET AL, "Purification and partial characterization of a 'short' insectotoxin-like peptide from the venom of the scorpion Parabuthus schlechteri", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, (19981228), vol. 441, no. 3, doi:10.1016/S0014-5793(98)01589-0, ISSN 0014-5793, pages 387 - 391, XP004258970 [A] 1-15 * figures 2,3 * DOI: http://dx.doi.org/10.1016/S0014-5793(98)01589-0 | [T] - AKCAN MUHARREM ET AL, "Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy.", JOURNAL OF MEDICINAL CHEMISTRY 10 FEB 2011, (20110210), vol. 54, no. 3, ISSN 1520-4804, pages 782 - 787, XP002699206 [T] 1-15 * abstract * DOI: http://dx.doi.org/10.1021/JM101018R | by applicant | US5171741 | US5171749 | US5173504 | US5308608 | US5405957 | US5512675 | US5726304 | US5739116 | US5773001 | US5831088 | US5877296 | US5880145 | US5905027 | US5929105 | US6028174 | US6319891 | US6429187 | WO03010475 | WO03101475 | WO03101474 | US6667156 | US6870029 | WO2005099774 | WO2009021136 | WO2009117018 | WO2009140599 | - NOGRADY, Medicinal Chemistry A Biochemical Approach, OXFORD UNIVERSITY PRESS, (1985), pages 388 - 392 | - WAGNER; MUSSO, "New Naturally Occuring Amino Acids", AGNEW. CHEM. INT. ED. ENGL., (1983), vol. 22, pages 816 - 828 | - MERRIFIELD, "Solid-phase peptide synthesis", ADV ENZYMOL RELAT AREAS MOL BIOL., (1969), vol. 32, pages 221 - 96 | - FRIDKIN ET AL., ANNU REV BIOCHEM., (1974), vol. 43, no. 0, pages 419 - 43 | - "Concept and Early Development of Solid Phase Peptide Synthesis", METHODS IN ENZYMOLOGY, (1997), vol. 289, pages 3 - 13 | - SABATINO ET AL., "Advances in automatic, manual and microwave-assisted solid-phase peptide synthesis", CURR OPIN DRUG DISCOV DEVEL., (2009), vol. 11, no. 6, pages 762 - 70 | - "Guide to Protein Purification", DEUTSCHER ET AL., Methods in Enzymology, ACADEMIC PRESS, (1990), vol. 192 | - Y.S. ZHEN ET AL., J. ANTIBIOT., (1989), vol. 42, pages 1294 - 1298 | - M.D. LEE ET AL., J. AM. CHEM. SOC., (1987), vol. 109, pages 3464 - 3466 | - M.D. LEE ET AL., J. AM. CHEM. SOC., (1987), vol. 109, pages 3466 - 3468 | - W.M. MAIESE ET AL., J. ANTIBIOT., (1989), vol. 42, pages 558 - 563 | - M.D. LEE ET AL., J. ANTIBIOT., (1989), vol. 42, pages 1070 - 1087 | - A. KALOTA ET AL., CANCER BIOL. THER., (2004), vol. 3, pages 4 - 12 | - Y. NAKATA ET AL., CRIT. REV. EUKARYOT. GENE EXPR., (2005), vol. 15, pages 163 - 182 | - V. WACHECK; U. ZANGMEISTER-WITTKE, CRIT. REV. ONCOL. HEMATOL., (2006), vol. 59, pages 65 - 73 | - A. KOLATA ET AL., Handb. Exp. Pharmacol., (2006), vol. 173, pages 173 - 196 | - P. HERDEWIJN ET AL., ANTISENSE NUCLEIC ACIDS DRUG DEV., (2000), vol. 10, pages 297 - 310 | - Y. SHOJI; H. NAKASHIMA, CURR. CHARM. DES., (2004), vol. 10, pages 785 - 796 | - A.W TONG ET AL., CURR. OPIN. MOL. THER., (2005), vol. 7, pages 114 - 124 | - R.A STAHEL ET AL., LUNG CANCER, (2003), vol. 41, pages S81 - S88 | - K.F. PIROLLO ET AL., PHARMACOL. THER., (2003), vol. 99, pages 55 - 77 | - A.C. STEPHENS; R.P. RIVERS, CURR. OPIN. MOL. THER., (2003), vol. 5, pages 118 - 122 | - N.M. DEAN; C.F. BENNETT, ONCOGENE, (2003), vol. 22, pages 9087 - 9096 | - N. SCHIAVONE ET AL., CURR. PHARM. DES., (2004), vol. 10, pages 769 - 784 | - L. VIDAL ET AL., EUR. J. CANCER, (2005), vol. 41, pages 2812 - 2818 | - T. ABOUL-FADL, CURR. MED. CHEM., (2005), vol. 12, pages 2193 - 2214 | - M.E. GLEAVE; B.P. MONIA, NAT. REV. CANCER, (2005), vol. 5, pages 468 - 479 | - Y.S. CHO-CHUNG, CURR. PHARM. DES., (2005), vol. 11, pages 2811 - 2823 | - E. RAYBURN ET AL., LETT. DRUG DESIGN & DISCOV., (2005), vol. 2, pages 1 - 18 | - E.R. RAYBURN ET AL., EXPERT OPIN. EMERG. DRUGS, (2006), vol. 11, pages 337 - 352 | - I. TAMM; M. WAGNER, MOL. BIOTECHNOL., (2006), vol. 33, pages 221 - 238 | - C.A. STEIN ET AL., SEMIN. ONCOL., (2005), vol. 32, pages 563 - 573 | - S.R. FRANKEL, SEMIN. ONCOL., (2003), vol. 30, pages 300 - 304 | - S. GOEL ET AL., CLIN. CANCER RES., vol. 203, no. 9, pages 4069 - 4076 | - S.P. HENRY ET AL., ANTICANCER DRUG DES., (1997), vol. 12, pages 409 - 420 | - B.P. MONIA ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 15481 - 15484 | - C.M. RUDIN ET AL., CLIN. CANCER RES., (2001), vol. 7, pages 1214 - 1220 | - J. KURRECK, EUR. J. BIOCHEM., (2003), vol. 270, pages 1628 - 1644 | - A. BIROCCIO ET AL., ONCOGENE, (2003), vol. 22, pages 6579 - 6588 | - Y. LEE ET AL., CANCER RES., (2003), vol. 63, pages 2802 - 2811 | - B. LU ET AL., CANCER RES., (2004), vol. 64, pages 2840 - 2845 | - A. RAIT ET AL., ANN. N. Y. ACAD. SCI., (2003), vol. 1002, pages 78 - 89 | - MCMANUS; SHARP, NATURE REV. GENET., (2002), vol. 3, page 737 | - ELBASHIR ET AL., GENES DEV., (2001), vol. 15, page 188 | - MILHAVET ET AL., PHARMACOL. REV., (2003), vol. 55, pages 629 - 648 | - F. BI ET AL., CURR. GENE. THER., (2003), vol. 3, pages 411 - 417 | - P.Y. LU ET AL., CURR. OPIN. MOL. THER., (2003), vol. 5, pages 225 - 234 | - I. FRIEDRICH ET AL., SEMIN. CANCER BIOL., (2004), vol. 14, pages 223 - 230 | - M. IZQUIERDO, CANCER GENE THER., (2005), vol. 12, pages 217 - 227 | - P.Y. LU ET AL., ADV. GENET., (2005), vol. 54, pages 117 - 142 | - G.R. DEVI, CANCER GENE THER., (2006), vol. 13, pages 819 - 829 | - M.A. BEHLKE, MOL. THER., (2006), vol. 13, pages 644 - 670 | - L.N. PUTRAL ET AL., DRUG NEWS PERSPECT., (2006), vol. 19, pages 317 - 324 | - T.R. BRUMMELKAMP ET AL., SCIENCE, (2002), vol. 296, pages 550 - 553 | - M.T. HEMMAN ET AL., NAT. GENET., (2003), vol. 33, pages 396 - 400 | - M. SCHERR ET AL., BLOOD, (2003), vol. 101, pages 1566 - 1569 | - M.J. LI ET AL., OLIGONUCLEOTIDES, (2003), vol. 13, pages 401 - 409 | - U. RITTER ET AL., OLIGONUCLEOTIDES, (2003), vol. 13, pages 365 - 373 | - T.F. LOU ET AL., OLIGONUCLEOTIDES, (2003), vol. 13, pages 313 - 324 | - T.R. BRUMMELKAMP ET AL., CANCER CELL, (2002), vol. 2, pages 243 - 247 | - G. YANG ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 4339 - 4345 | - M. VAN DE WETERING ET AL., EMBO REP., (2003), vol. 4, pages 609 - 615 | - SIGGEL ET AL., J. PHYS. CHEM., (1996), vol. 100, pages 2070 - 2075 | - PETERSON ET AL., CANCER RES., (1996), vol. 56, pages 3980 - 3985 | - OMELYANENKO ET AL., INT. J. CANCER, (1998), vol. 75, pages 600 - 608 | - R.W. REDMOND; J.N. GAMLIN, PHOTOCHEM. PHOTOBIOL., (1999), vol. 70, pages 391 - 475 | - AMORINO ET AL., RADIAT. ONCOL. INVESTIG., (1999), vol. 7, pages 343 - 352 | - CHOY, ONCOLOGY, (1999), vol. 13, pages 22 - 38 | - SAFRAN ET AL., CANCER INVEST., (2001), vol. 19, pages 1 - 7 | - DIONET ET AL., ANTICANCER RES., (2002), vol. 22, pages 721 - 725 | - CIVIDALLI ET AL., RADIAT. ONCOL. BIOL. PHYS., (2002), vol. 52, pages 1092 - 1098 | - CHOY, ONCOLOGY, (2000), vol. 14, pages 7 - 14 | - MORNEX; GIRARD, ANNALS OF ONCOLOGY, (2006), vol. 17, pages 1743 - 1747 | - INANAMI ET AL., INT. J. RADIAT. BIOL., (2002), vol. 78, pages 267 - 274 | - TAMULEVICIUS ET AL., BR. J. RADIOLOGY, (1981), vol. 54, pages 318 - 324 | - PALCIC ET AL., RADIAT. RES., (1984), vol. 100, pages 340 - 347 | - MASUNAGA ET AL., BR. J. RADIOL., (2006), vol. 79, pages 991 - 998 | - RISCHIN ET AL., J. CLIN. ONCOL., (2001), vol. 19, pages 535 - 542 | - SHULMAN ET AL., INT. J. RADIAT. ONCOL. BIOL. PHYS., (1999), vol. 44, pages 349 - 353 | - BUCHHOLZ ET AL., INT. J. RADIAT. ONCOL. BIOL. PHYS., (1995), vol. 32, pages 1053 - 1058 | - SOGAARD ET AL., "Antibody- targeted superantigens in cancer immunotherapy", IMMUNOTECHNOLOGY, (1996), vol. 2, no. 3, pages 151 - 162 | - GIANTONIO ET AL., J. CLIN. ONCOL., (1997), vol. 15, pages 1994 - 2007 | - ALPAUGH ET AL., CLIN. CANCER RES., (1998), vol. 4, pages 1903 - 1914 | - CHENG ET AL., J. CLIN. ONCOL., (2004), vol. 22, pages 602 - 609 | - TERMAN ET AL., CLIN. CHEST MED., (2006), vol. 27, pages 321 - 324 | - PERABO ET AL., INT. J. CANCER, (2005), vol. 115, pages 591 - 598 | - BAGSHAWE ET AL., CURRENT OPINIONS IN IMMUNOLOGY, (1999), vol. 11, pages 579 - 583 | - WILMAN, "Prodrugs in Cancer Therapy", BIOCHEMICAL SOCIETY TRANSACTIONS, (1986), vol. 14, pages 375 - 382 | - "Prodrugs: A Chemical Approach To Targeted Drug Delivery", STELLA ET AL., Directed Drug Delivery, HUMANA PRESS, (1985), pages 247 - 267 | - ROOSEBOOM ET AL., PHARMACOL. REVIEWS, (2004), vol. 56, pages 53 - 102 | - The Handbook of Fluorescent Probes and Research Products, MOLECULAR PROBES, INC. |